Furthermore, MEG3 has the ability to hinder the PI3K/Akt signaling cascade by modulating downstream effector molecules, including PTEN (phosphatase and tensin homologue), a significant tumor suppressor that inhibits the PI3K/Akt signaling cascade through dephosphorylating PIP3[81,86]. The gene discussed is AKT1; the disease is neoplasm.